Profluent Bio
Latest round
- Series B
Last raised
- Nov 2025
Total raised
- $115M
Investors
- 8
About Profluent Bio
Founded in 2022 and based in California, US, Profluent Bio Inc. operates as a biotechnology company that develops novel functional proteins. The company was founded by its CEO, Ali Madani. In November 2025, Profluent Bio Inc. Profluent Bio provides an artificial intelligence-based protein design research platform that leverages deep generative models, mainly machine learning models, to design and develop novel functional proteins, mainly biomolecules, for human health and industrial applications. The firm's AI-based biotechnology research platform decodes proteins with the help of deep generative models.
Who invested in Profluent Bio
8 investors across 2 rounds
See all investors in Profluent Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Profluent Bio
Who invested in Profluent Bio?
Profluent Bio has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Profluent Bio raised?
Profluent Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Profluent Bio last raise money?
Profluent Bio's most recent round on record is a Series B, in Nov 2025.
What does Profluent Bio do?
Founded in 2022 and based in California, US, Profluent Bio Inc.
Where is Profluent Bio headquartered?
Profluent Bio is headquartered in Emeryville, US.
Which VCs invest in companies like Profluent Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Profluent Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Profluent Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.